Hood River Capital Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 851,400 shares of CRNX stock, worth $29.9 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
851,400
Previous 834,912
1.97%
Holding current value
$29.9 Million
Previous $42.6 Million
2.08%
% of portfolio
0.75%
Previous 0.79%
Shares
3 transactions
Others Institutions Holding CRNX
# of Institutions
254Shares Held
82.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$319 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$218 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$215 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$190 Million0.03% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.29MShares$150 Million10.24% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.89B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...